According to experts
in this field, the industry is investigating antibodies against novel targets
which are expected to drive the market in the coming years. In fact, many
service provider and platform provider companies are offering support to the
medical research community in order to develop an appropriate intervention to
treat the illness caused by the SARS-CoV-2 virus.
To order this 500+
page report, which features 120+ figures and 140+ tables, please visit this link
The USD 6.5
billion (by 2030) financial opportunity within the antibody discovery services market
has been analyzed across the following segments:
§
- Antigen Designing
- Hit Generation
- Lead Selection
- Lead Optimization
- Lead Characterization
§
- Phage Display
- Hybridoma
- Transgenic Animal
- Yeast Display
- Single Cell
- Others
§
- Humanized
- Human
- Chimeric
- Murine
§
- North America
- Europe
- Asia Pacific and Rest of the World
The USD 5.9
billion (by 2030) financial opportunity within the antibody discovery platforms
market has been analysed across the following segments:
§
- Upfront Payments
- Milestone Payments
§
- North America
- Europe
- Asia Pacific
The Antibody Discovery:
Services and Platforms Market (3rd Edition), 2020-2030 report features the
following companies, which we identified to be key players in this domain:
§
§
§
§
§
§
§
Press Release:
Variation 3 (Format 4)
§
§
§
§
§
§
§
§
§
§
§
§
Table of Contents
1.
Preface
4. Antibody
Discovery Process and Methods
5. Antibody
Discovery Service Providers: Current Market Landscape
6. Company
Competitiveness Analysis
7. Company
Profiles: Antibody Discovery Service Providers
8. Antibody
Discovery Technologies: Current Market Landscape
9. Technology
Competitiveness Analysis
10. Company
Profiles: Antibody Discovery Platform Providers
11. Regional
Capability Analysis
12. Partnerships
and Collaborations
13. Funding
and Investment Analysis
14. Antibody
Discovery Services: Market Forecast
15. Antibody
Discovery Technologies: Market Forecast
16. Case
in Point: Drug Discovery Processes of Top Selling Antibodies
17. Case
Study: Antibody Humanization and Affinity Maturation
18. Future
Growth Opportunities
19. Executive
Insights
20. Concluding
Remarks
21. Appendix
1: Tabulated Data
22. Appendix
2: List of Companies and Organizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/antibody-discovery-services-and-platforms/213.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
